Trial Profile
Modulation of cerebral somatosensory processing and nociception by treatment with botulinum toxin A in spasticity and dystonia
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dystonia; Muscle spasticity
- Focus Therapeutic Use
- 11 May 2012 New trial record